ROCKVILLE, MD, Sept. 26, 2022 (GLOBE NEWSWIRE) — Job changes, salary increases and new work environments are among the top findings of a new Regulatory Affairs Professionals Society (RAPS) study of the medical regulatory industry. The 2022 Global Compensation and Scope of Practice Report, the largest and most comprehensive research initiative on the global regulatory profession, revealed major changes in this area over the past two years.
“RAPS has been researching the work and compensation of regulatory professionals for nearly 30 years,” said Denise Fulton, RAPS vice president, research & content strategy. “The 2022 report highlights some real changes in this environment and is a valuable tool in enabling regulators to better understand the professional landscape and its capabilities.”
In response to the 2022 survey, nearly 2,000 regulatory agencies involved with pharmaceuticals throughout the product lifecycle answered questions about their compensation, job responsibilities, professional and educational background, and more.
The report contains complete and accurate compensation data from individuals working in the regulatory industry. It aims to enable organizations and individuals, as well as recruiters and hiring managers, to compare their compensation and workload to that of their peers.
This report shows compensation information for respondents in the US, Canada, and Europe. The average total compensation for US-based regulatory professionals in 2022 ranged from $355,575 for vice presidents to $101,294 for associates. Respondents reported a 6.7 percent increase in base pay from 2020 to 2021. The report also tracks which professionals received the largest pay rises in 2021, with those accepting positions at a new company reporting the largest increase — 19 .2 percent.
It also includes data on how regulatory professionals and the companies they work for are tackling the complex issues facing workers and employers today. In the age of the ‘Great Resignation’, this report provides data on regulators’ career motivations and attitudes towards their companies. The report shows regulatory professionals returning to the office, with just one in seven respondents describing their work situation as “personal”.
For more information, see: Scope of Practice Survey | canola.
